70
Views
7
CrossRef citations to date
0
Altmetric
Hypothesis

Activation of IL-8 and its participation in cancer in schizophrenia patients: new evidence for the autoimmune hypothesis of schizophrenia

, , &
Pages 3393-3403 | Published online: 13 Dec 2018

References

  • FreedmanRSchizophreniaN Engl J Med2003349181738174914585943
  • GaneshSAshokAHKumarCNThirthalliJPrevalence and determinants of metabolic syndrome in patients with schizophrenia: a systematic review and meta-analysis of Indian studiesAsian J Psychiatr201622869227520904
  • HornigMMervisRHoffmanKLipkinWIInfectious and immune factors in neurodevelopmental damageMol Psychiatry200272S34S3512142943
  • RundBRIs schizophrenia a neurodegenerative disorder?Nord J Psychiatry200963319620119235629
  • AghajanianGKMarekGJSerotonin model of schizophrenia: emerging role of glutamate mechanismsBrain Res Rev2000312–330231210719157
  • HarrisonPJWeinbergerDRSchizophrenia genes, gene expression, and neuropathology: on the matter of their convergenceMol Psychiatry2005101406815263907
  • NaKSJungHYKimYKThe role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophreniaProg Neuropsychopharmacol Biol Psychiatry20144827728623123365
  • JonesALMowryBJPenderMPGreerJMImmune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?Immunol Cell Biol200583191715661036
  • XuMHeLConvergent evidence shows a positive association of interleukin-1 gene complex locus with susceptibility to schizophrenia in the Caucasian populationSchizophr Res20101201–313114220347268
  • KunzMCeresérKMGoiPDSerum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balanceBraz J Psychiatr201133326827421971780
  • LinAKenisGBignottiSThe inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6Schizophr Res19983219159690329
  • ZhangXYZhouDFCaoLYZhangPYWuGYShenYCChanges in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophreniaJ Clin Psychiatry200465794094715291683
  • AvguštinBWraberBPesekMBTavcarRIncreased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia and chronic schizophreniaBrain Behav Immun2005194268274
  • DoorduinJde VriesEFWillemsenATde GrootJCDierckxRAKleinHCNeuroinflammation in schizophrenia-related psychosis: a PET studyJ Nucl Med200950111801180719837763
  • van BerckelBNBossongMGBoellaardRMicroglia activation in recent-onset schizophrenia: a quantitative (R)-11PK11195 positron emission tomography studyBiol Psychiatry200864982082218534557
  • KurumajiAWakaiTToruMDecreases in peripheral-type benzodiazepine receptors in postmortem brains of chronic schizophrenicsJ Neural Transm (Vienna)199710411–12136113709503282
  • WolfSABoddekeHWKettenmannHMicroglia in physiology and diseaseAnnu Rev Physiol201779161964327959620
  • FrankMGBarattaMVSprungerDBWatkinsLRMaierSFMicroglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responsesBrain Behav Immun2007211475916647243
  • AloisiFImmune function of microgliaGlia200136216517911596125
  • WrightPShamPCGilvarryCMJonesPBCannonMSharmaTMurrayRMAutoimmune diseases in the pedigrees of schizophrenic and control subjectsSchizophr Res19962032612678827852
  • OthmanSSAbdul KadirKHassanJHongGKSinghBBRamanNHigh prevalence of thyroid function test abnormalities in chronic schizophreniaAust N Z J Psychiatry19942846206247794205
  • ShimaSYanoKSugiuraMTokunagaYAnticerebral antibodies in functional psychosesBiol Psychiatry19912943223282036476
  • HeathRGMcCarronKLO’NeilCEAntiseptal brain antibody in IgG of schizophrenic patientsBiol Psychiatry19892567257332923934
  • HennebergAEHorterSRuffertSIncreased prevalence of antibrain antibodies in the sera from schizophrenic patientsSchizophr Res199414115227893617
  • BordaTGomezRBerríaMISterin-BordaLAntibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients’ seraGlia200445214415414730708
  • TanabeMKanehisaMUsing the KEGG database resourceCurr Protoc Bioinformatics2012 Chapter 1: Unit 1.12
  • KamburovAStelzlULehrachHHerwigRThe ConsensusPathDB interaction database: 2013 updateNucleic Acids Res201341 Database issue D793–D800
  • JupeSAkkermanJWSoranzoNOuwehandWHReactome – a curated knowledgebase of biological pathways: megakaryocytes and plateletsJ Thromb Haemost201210112399240222985186
  • SchaeferCFAnthonyKKrupaSBuchoffJDayMHannayTBuetowKHPID: the Pathway Interaction DatabaseNucleic Acids Res200937Database issueD674D67918832364
  • KamburovAPentchevKGalickaHWierlingCLehrachHHerwigRConsensusPathDB: toward a more complete picture of cell biologyNucleic Acids Res201139Database issueD712D71721071422
  • AllenNCBagadeSMcQueenMBSystematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene databaseNat Genet200840782783418583979
  • BarrettTWilhiteSELedouxPNCBI GEO: archive for functional genomics data sets-updateNucleic Acids Res201341Database issueD991D99523193258
  • SubramanianAKuehnHGouldJTamayoPMesirovJPGSEA-P: a desktop application for Gene Set Enrichment AnalysisBioinformatics200723233251325317644558
  • KimKJutooruIChadalapakaGHOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancerOncogene201332131616162522614017
  • Gene Set Enrichment Analysis [homepage on the Internet]GSEA User Guide [updated 2012 Dec cited 2018 Nov 26] Available from: http://software.broadinstitute.org/gsea/doc/GSEAUserGuideFrame.htmlAccessed November 26, 2018
  • CappelloFde MacarioECZummoGMacarioAJImmunohistochemistry of human Hsp60 in health and disease: from autoimmunity to cancerMethods Mol Biol201178724525421898240
  • GuptaSMukherjeeSSyedPEvaluation of autoantibody signatures in meningioma patients using human proteome arraysOncotarget2017835584435845628938569
  • EscribeseMMBarberDNew insight into cancer immunotherapyAllergol Immunopathol (Madr)201745Suppl 1505529108766
  • TosoniAFranceschiEPasquiniEImmunotherapy in head and neck cancer: evidence and perspectivesImmunotherapy20179161351135829185392
  • RudqvistNPPilonesKALhuillierCRadiotherapy and CTLA-4 blockade shape the TCR repertoire of tumor-infiltrating T cellsCancer Immunol Res20186213915029180535
  • DomblidesCAntoineMHamardCNon-small cell lung cancer from HIV-infected patients expressed PD-L1 with marked inflammatory infiltratesAIDS2017324461469
  • RealeMPatrunoADe LutiisMADysregulation of chemocytokine production in schizophrenic patients versus healthy controlsBMC Neurosci20111211321266029
  • LeviteMChowersYNerve-driven immunity: neuropeptides regulate cytokine secretion of T cells and intestinal epithelial cells in a direct, powerful and contextual mannerAnn Oncol200112Suppl 2S19S2511762346
  • ElenkovIJWilderRLChrousosGPViziESThe sympathetic nerve – an integrative interface between two supersystems: the brain and the immune systemPharmacol Rev200052459563811121511
  • CuiGBAnJZZhangNZhaoMGLiuSBYiJElevated interleukin-8 enhances prefrontal synaptic transmission in mice with persistent inflammatory painMol Pain201281122325008
  • LeeKHKronbichlerAParkDDNeutrophil extracellular traps (NETs) in autoimmune diseases: a comprehensive reviewAutoimmun Rev201716111160117328899799
  • SolimanEHendersonKLDanellASVan DrossRArachidonoyl-ethanolamide activates endoplasmic reticulum stress-apoptosis in tumorigenic keratinocytes: role of cyclooxygenase-2 and novel J-series prostamidesMol Carcinog201655211713025557612
  • YangXXuYWangTInhibition of cancer migration and invasion by knocking down delta-5-desaturase in COX-2 overexpressed cancer cellsRedox Biol20171165366228157665
  • YanDAnGKuoMTC-Jun N-terminal kinase signalling pathway in response to cisplatinJ Cell Mol Med201620112013201927374471
  • KochPGehringerMLauferSAInhibitors of c-Jun N-terminal kinases: an updateJ Med Chem2015581729525415535
  • ZhaoHFWangJTony ToSSThe phosphatidylinositol 3-kinase/Akt and c-Jun N-terminal kinase signaling in cancer: alliance or contradiction? (Review)Int J Oncol201547242943626082006
  • WangLZhangCXuJWuHPengJCaiSHeYCXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancerMol Med Rep20161454673467927748927
  • FondGMacgregorAAttalJLarueABrittnerMDucasseDCapdevielleDAntipsychotic drugs: pro-cancer or anti-cancer? A systematic reviewMed Hypotheses2012791384222543071
  • JablenskyALawrenceDSchizophrenia and cancer: is there a need to invoke a protective geneArch Gen Psychiatry200158657958011386987
  • BarakYAchironAMandelMMireckiIAizenbergDReduced cancer incidence among patients with schizophreniaCancer2005104122817282116288491
  • MortensenPBThe incidence of cancer in schizophrenic patientsJ Epidemiol Community Health198943143472592890
  • LinGMChenYJKuoDJCancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997–2009Schizophr Bull201339240741622045828
  • MarkowskaALubinJMarkowskaJKasprzakBChajewska-CzekańskaMMadryRStawickaMMultiple primary cancers in BRCA 1/2 carriers – a review of literature and our observationsEur J Gynaecol Oncol201738336136329693873
  • WeirHKJohnsonCJWardKCColemanMPThe effect of multiple primary rules on cancer incidence rates and trendsCancer Causes Control201627337739026809509
  • KongPWuRLanYAssociation between mismatch-repair genetic variation and the risk of multiple primary cancers: a meta-analysisJ Cancer20178163296330829158803
  • BrownJSCancer immune equilibrium and schizophrenia have similar interferon-γ, tumor necrosis factor-α, and interleukin expression: a tumor model of schizophreniaSchizophr Bull20164261407141727169466
  • LiangFZhangSXueHChenQRisk of second primary cancers in cancer patients treated with cisplatin: a systematic review and meta-analysis of randomized studiesBMC Cancer201717187129258467
  • LimMCWonYJLimJSecond primary cancer after diagnosis and treatment of cervical cancerCancer Res Treat201648264164926194366
  • YouldenDRYoulPHPeter SoyerHFritschiLBaadePDMultiple primary cancers associated with Merkel cell carcinoma in Queensland, Australia, 1982–2011J Invest Dermatol2014134122883288924991966
  • HasanAFalkaiPWobrockTWFSBP Task Force on Treatment Guidelines for SchizophreniaWorld Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia – a short version for primary careInt J Psychiatry Clin Pract2017212829028498090
  • HodgsonRWildgustHJBusheCJCancer and schizophrenia: is there a paradox?J Psychopharmacol2010244 Suppl5160
  • JiJSundquistKNingYKendlerKSSundquistJChenXIncidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in SwedenSchizophr Bull201339352753622522642